$Grab Holdings (GRAB.US)$ Grab is giving big discounts for their food service right now in Indonesia. Gojek is giving less, and shopee is the least.

$Pfizer (PFE.US)$ said that it has begun a rolling submission of its COVID-19 antiviral Paxlovid (PF-07321332 and ritonavir) with Health Canada.
The submission includes an analysis of data from a phase 2/3 trial.
Paxlovid is intended for treatment of mild to moderate COVID-19 in adults at increased risk of hospitalizations or death.
Pfizer sought Emergency Use Authorization for Paxlovid with the FDA last month.

$Ford Motor (F.US)$ Dude, Ford goes through a crisis every ten years or so. Ford Treasury is very conservative and has been in the debt business for longer than we have been alive. They're very conservative and have been correct more often than not, often in times of crises. Not saying they are perfect but I would give them the benefit of the doubt specifically when it comes to bonds and debt. Just my 2 cents based on observing Ford since 1990.

$Rivian Automotive (RIVN.US)$ One of the easiest shorts ever. Using money I can lose and if they pump this fomo crap higher I'll incrementally add. Mark that it will be either 90% lower or bankrupt some day in the near enough future. This market is full of these fomo short opps given all the gambling everyone is doing.

$General Motors (GM.US)$ EVs have their place in the market as do diesels and gas. Needs drive product choice.
What will be interesting is the integration of time-of-use-rates (electric) and EV charging at scale.
Price at the pump is constant (meaning no significant intra-day price swings) any time one wishes to fill up. Not so with time-of-use rates especially when the grid is stressed.

$Pfizer (PFE.US)$ and its partner $BioNTech (BNTX.US)$ plan to ask the FDA in the next few days to authorize booster shots of its COVID-19 vaccine for 16 and 17 year olds, The Washington Post reports.
Two sources told the newspaper that the agency is expected to quickly sign off on the request.
New data from Israel on boosters in this age group is said to have reassured the FDA that cases of myocarditis, an inflammation of the heart muscle, in men is very rare.
The CDC today said that all adults 18 and over should get a booster shot in light of the potential impact of the Omicron variant.

$Pfizer (PFE.US)$ and $Merck & Co (MRK.US)$ have agreed to give licenses to firms in Vietnam to produce COVID-19 treatment pills, Vietnam's ministry of health said on Friday - Reuters.
In a statement, the ministry said that the companies have sent letters of approval to the Drug Administration of Vietnam for the production of Molnupiravir and Paxlovid pills.
Five local pharmaceutical companies have shown their interest in acquiring the license for producing Molnupiravir.
Last week, Pfizer said it would allow generic manufacturers to supply its experimental antiviral COVID-19 pill to low- and middle-income countries through a voluntary licensing agreement.

$General Motors (GM.US)$ I'm currently working on a battery operated plane. When I finish it - next week!!- I expect the finished plane to weigh about 2 lbs, and carry at least 6 ounces of cargo on a flight of at least 100 yards.
I can scale it all - if I can get it to IPO. anyone want in?

Sentiment is REALLY strong this time, and even though numbers are good tools, it seems to be a very strong force in the market. So many $Tesla (TSLA.US)$ shorts have capitulated. It is hard to imagine it falling to be reasonably valued which would mean a decline of well over 90%.

A report that Warburg Pincus has significantly cut the valuation of $Alibaba (BABA.US)$ affiliate Ant Group had little residual impact on the Chinese Internet retailing giant as trading progressed on Wednesday.
Warburg said it is now valuing financial technology company Ant at about $191 billion, or 15% less than the $224 valuation tag it gave Ant at the end of June. According to a report from Reuters, Warburg has changed its valuation of Ant due to "regulatory developments and the impact of ongoing restructuring."
Warburg also reportedly has said that it doesn't believe Ant's plans for a U.S. IPO will take place any time soon. Ant put its IPO plans on hold earlier this year after the company was ordered by Chinese government regulators to restructure itself into a financial holding company. That edict was part of an ongoing crackdown by Beijing on the business practices of many of China's leading tech giants.
Alibaba, which owns approximately 33% of Ant Group, saw its shares edge up by about 1%, Wednesday. Among other leading Chinese Internet companies, $Baidu (BIDU.US)$ remained near its breakeven line at around $150 a share. Susquehanna analyst Shyam Patil cut his price target on Alibaba to $200 a share from $310, and lowered his estimates on Baidu to $175 a share from $200. Patel cited concerns about the Covid-19 situation in China for his price-target cuts.
On Tuesday, Chinese regulators were said to have been putting pressure on Alibaba (BABA) and Baidu to clamp down on their platforms being used for fraudulent business practices.